✨ Free AI Report
Owlstone Medical: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Owlstone Medical
Company Research

Owlstone Medical: Business Overview, Financials & Competitive Analysis

Owlstone Medical, founded in 2004, is a developer of non-invasive breath-based diagnostics for cancer and infectious diseases. The Breath Biopsy platform is creating a new industry category based on routine detection ...

Analyst-debate audio for Owlstone Medical

AskCyborg analysts argue the bull and bear cases for Owlstone Medical across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
8/ 10Strong

Cyborg Score thesis

Deep-tech breath diagnostics platform with fortress IP, major government validation, and pharmaceutical partnerships, facing...

Read the full analyst-debate transcript →
Industry In-Vitro Diagnostics
1 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: November 2, 2026
AI-Generated Research
30+ Page Report

Get the Latest Owlstone Medical Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Owlstone Medical Overview

Pro stress-test →

Owlstone Medical, founded in 2004, is a developer of non-invasive breath-based diagnostics for cancer and infectious diseases. The Breath Biopsy platform is creating a new industry category based on routine detection and analysis of volatile organic compound (VOC) biomarkers in breath, which has the potential to revolutionize healthcare.

Strategic Profile

Pro stress-test →

The company's vision is to save 100,000 lives and $1.5 billion in healthcare costs through breath-based diagnostics. In November 2025, Owlstone won an award of up to $49.1 million from the Advanced Research Projects Agency for Health (ARPA-H) to develop at-home tests for early detection of multiple cancers. Research Products and Services are deployed at over 100 sites worldwide with major pharmaceutical companies including AstraZeneca, Actelion, and GlaxoSmithKline.

Competitive Landscape

Pro stress-test →

Key competitors include Aerocrine, GattyInstruments, and Health Mirror. Owlstone faces indirect competition from traditional diagnostic modalities (endoscopy, imaging, blood tests) and emerging breath/biomarker companies. Owlstone's competitive moat lies in its proprietary VOC analysis platform, commercial-scale laboratory infrastructure, and 160+ patent portfolio.

Industry Context

Owlstone Medical operates in In-Vitro Diagnostics.

Key facts

Founded: 2004 · Headquarters: Cambridge, United Kingdom

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Owlstone Medical.

  • ARPA-H POSEIDON award (November 2025) targets development of first-in-class multi-cancer early detection test for 30+ solid tumors using breath and urine samples in home setting.
  • Cystic Fibrosis Foundation investment of $2.3M (March 2025) to develop breath test for Pseudomonas aeruginosa detection in CF patients.
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • May 2026Series E funding status confirmed with $167M total raised across 17 funding rounds
  • March 2025Secured $2.3M equity investment from Cystic Fibrosis Foundation for PA detection breath test
  • +2 moreTrack every material event for Owlstone Medical as it happens. Explore monitoring →
Get alerted when Owlstone Medical has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Breath DiagnosticsNon-invasive breath-based lung cancer screening using VOC biomarker analysis→

Compare Owlstone Medical with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Owlstone Medical operates in In-Vitro Diagnostics. See how the rest of the sector scores on the Cyborg framework.

Browse In-Vitro Diagnostics research →
NEW · MCP server

Ask your AI assistant about Owlstone Medical

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Owlstone Medical and its top competitor on Cyborg Score”
“What did Owlstone Medical do this quarter?”
“Is Owlstone Medical a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com (you must copy support@askcyborg.com) · Terms of Service

Frequently asked questions

What does Owlstone Medical do?+
Owlstone Medical, founded in 2004, is a developer of non-invasive breath-based diagnostics for cancer and infectious diseases. The Breath Biopsy platform is creating a new industry category based on routine detection ...
What is Owlstone Medical's Cyborg Score?+
Owlstone Medical has a Cyborg Score of 8/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Owlstone Medical's main competitors?+
Named competitors include Breath Diagnostics. The full competitive landscape is in the AskCyborg report.
How can I get the full Owlstone Medical research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Owlstone Medical research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Owlstone Medical over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More In-Vitro Diagnostics research

Companies in the same sector and named competitors, ranked by Cyborg Score.

7DiaSorin S.p.A.7Shenzhen New Industries Biomedical Engineering Co., Ltd.4Biosynex SA